| Schedule of Related Party Transactions |
Amounts due from related party consisted of the following as of June 30, 2025 and December 31, 2024:
| | | June 30,
2025 | | December 31,
2024 | | | | (Unaudited) | | | | Current | | | | | | | | | | Libra Sciences Limited (Note b) | | $ | 519,002 | | | $ | 522,192 | | | Allowance for credit loss | | | (519,002 | ) | | | (522,192 | ) | | Total | | $ | — | | | $ | — | | Amounts due to related parties consisted of the following as of June 30, 2025 and December 31, 2024:
| | | June 30,
2025 | | December 31,
2024 | | | | (Unaudited) | | | | Current | | | | | | | | Aeneas Group Limited (Note a) | | $ | 79,180 | | $ | 79,180 | | Ian Huen | | | 520 | | | 464 | | | | $ | 79,700 | | $ | 79,644 |
|
|
|
June 30,
2025
|
|
December 31,
2024
|
| |
|
(Unaudited)
|
|
|
|
Convertible notes to a related party — Current
|
|
|
|
|
|
|
|
Jurchen Investment Corporation (Note 15)
|
|
$
|
—
|
|
$
|
3,238,500 |
| |
|
|
|
|
|
|
|
Convertible notes to a related party — Non-current
|
|
|
|
|
|
|
|
Jurchen Investment Corporation (Note 15)
|
|
$
|
3,328,500 |
|
$
|
—
|
|
|
|
For the six months
ended June 30,
|
| |
|
2025
|
|
2024
|
| |
|
(Unaudited)
|
|
(Unaudited)
|
|
Interest expenses (Note 15)
|
|
|
|
|
|
|
– Jurchen Investment Corporation
|
|
$
|
90,000 |
|
90,000 |
|
Related party transactions consisted of the following for the years ended December 31, 2024, 2023 and 2022:
|
|
|
Year ended
December 31,
2024
|
|
Year ended
December 31,
2023
|
|
Year ended
December 31,
2022
|
|
Loan from related parties (Note a)
|
|
|
|
|
|
|
|
|
|
|
|
– Aeneas Group Limited
|
|
$
|
—
|
|
$
|
2,500,000 |
|
|
$
|
500,000 |
| |
|
|
|
|
|
|
|
|
|
|
|
Issuance of Convertible Note to related parties (Note 15)
|
|
|
|
|
|
|
|
|
|
|
|
– Jurchen Investment Corporation
|
|
$
|
—
|
|
$
|
3,000,000 |
|
|
$
|
—
|
|
– Aenco Technologies Ltd
|
|
$
|
—
|
|
$
|
—
|
|
|
$
|
3,000,000 |
| |
|
|
|
|
|
|
|
|
|
|
|
Settlement of loan from a related party through issuance of Convertible Note (Note 15)
|
|
|
|
|
|
|
|
|
|
|
|
– Aeneas Group Limited
|
|
$
|
—
|
|
$
|
3,000,000 |
|
|
$
|
—
|
| |
|
|
|
|
|
|
|
|
|
|
|
Interest expenses (Note a and Note 15)
|
|
|
|
|
|
|
|
|
|
|
|
– Aeneas Group Limited
|
|
$
|
—
|
|
$
|
71,123 |
|
|
$
|
8,110 |
|
– Jurchen Investment Corporation
|
|
$
|
180,000 |
|
$
|
58,500 |
|
|
$
|
—
|
|
– Aenco Technologies Ltd
|
|
$
|
—
|
|
$
|
(13,234 |
)
|
|
$
|
13,234 |
| |
|
|
|
|
|
|
|
|
|
|
|
Loan to related parties (Note b)
|
|
|
|
|
|
|
|
|
|
|
|
– Libra Sciences Limited
|
|
$
|
—
|
|
$
|
92,459 |
|
|
$
|
330,341 |
| |
|
|
|
|
|
|
|
|
|
|
|
Loan repayment and interest received from a related party (Note b)
|
|
|
|
|
|
|
|
|
|
|
|
– Talem Medical Group Limited
|
|
$
|
—
|
|
$
|
611,641 |
|
|
$
|
2,962,153 |
| |
|
|
|
|
|
|
|
|
|
|
|
Interest income (Note b)
|
|
|
|
|
|
|
|
|
|
|
|
– Talem Medical Group Limited
|
|
$
|
—
|
|
$
|
4,637 |
|
|
$
|
164,600 |
|
– Libra Sciences Limited
|
|
$
|
—
|
|
$
|
8,963 |
|
|
$
|
14,232 |
| |
|
|
|
|
|
|
|
|
|
|
|
Consultant, secondment, management and administrative services fees (Note c)
|
|
|
|
|
|
|
|
|
|
|
|
– CGY Investments Limited
|
|
$
|
—
|
|
$
|
153,640 |
|
|
$
|
268,102 |
|
– ACC Medical Limited
|
|
$
|
—
|
|
$
|
138,768 |
|
|
$
|
209,626 |
| |
|
|
|
|
|
|
|
|
|
|
|
Administrative management services (Note d)
|
|
|
|
|
|
|
|
|
|
|
|
– Libra Sciences Limited
|
|
$
|
—
|
|
$
|
9,615 |
|
|
$
|
38,462 |
| |
|
|
|
|
|
|
|
|
|
|
|
Healthcare services income
|
|
|
|
|
|
|
|
|
|
|
|
– Aeneas Management Limited
|
|
$
|
—
|
|
$
|
961 |
|
|
$
|
1,282 |
|